8-K/AThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Feb 1, 2021 · 5y ago · Accession 0001104659-21-009794
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Theriva Biologics, Inc.
- Ticker
- TOVX
- CIK
- 894158
- Form type
- 8-K/A
- Filing date
- Feb 1, 2021
- Report date
- Jan 27, 2021
- Document
- tm214840d1_8ka.htm
- Size
- 420 KB